Abstract
Seventy five percent of hospitalized patients with Crohn’s disease suffer from malnutrition. One third of Crohn’s disease patients have a body mass index below 20. Sixty percent of Crohn’s disease patients have sarcopenia. However some inflammatory bowel disease (IBD) patients are obese or suffer from sarcopenic-obesity. IBD patients have many vitamin and nutrient deficiencies, which can lead to important consequences such as hyperhomocysteinemia, which is associated with a higher risk of thromboembolic disease. Nutritional deficiencies in IBD patients are the result of insufficient intake, malabsorption and protein-losing enteropathy as well as metabolic disturbances directly induced by the chronic disease and its treatments, in particular corticosteroids. Screening for nutritional deficiencies in chronic disease patients is warranted. Managing the deficiencies involves simple nutritional guidelines, vitamin supplements, and nutritional support in the worst cases.
Keywords: Crohn's disease, enteral nutrition, malnutrition, metabolism, nutrition, obesity, osteopenia, parenteral nutrition, sarcopenia, ulcerative colitis, vitamins.
Current Drug Targets
Title:Nutrition in Adult Patients with Inflammatory Bowel Disease
Volume: 15 Issue: 11
Author(s): Xavier Hebuterne, Jerome Filippi and Stephane M. Schneider
Affiliation:
Keywords: Crohn's disease, enteral nutrition, malnutrition, metabolism, nutrition, obesity, osteopenia, parenteral nutrition, sarcopenia, ulcerative colitis, vitamins.
Abstract: Seventy five percent of hospitalized patients with Crohn’s disease suffer from malnutrition. One third of Crohn’s disease patients have a body mass index below 20. Sixty percent of Crohn’s disease patients have sarcopenia. However some inflammatory bowel disease (IBD) patients are obese or suffer from sarcopenic-obesity. IBD patients have many vitamin and nutrient deficiencies, which can lead to important consequences such as hyperhomocysteinemia, which is associated with a higher risk of thromboembolic disease. Nutritional deficiencies in IBD patients are the result of insufficient intake, malabsorption and protein-losing enteropathy as well as metabolic disturbances directly induced by the chronic disease and its treatments, in particular corticosteroids. Screening for nutritional deficiencies in chronic disease patients is warranted. Managing the deficiencies involves simple nutritional guidelines, vitamin supplements, and nutritional support in the worst cases.
Export Options
About this article
Cite this article as:
Hebuterne Xavier, Filippi Jerome and Schneider M. Stephane, Nutrition in Adult Patients with Inflammatory Bowel Disease, Current Drug Targets 2014; 15 (11) . https://dx.doi.org/10.2174/1389450115666140930150047
DOI https://dx.doi.org/10.2174/1389450115666140930150047 |
Print ISSN 1389-4501 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-5592 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Subject Index To Volume 3
Vascular Disease Prevention (Discontinued) 5-HT3 Receptors
Current Pharmaceutical Design Organ Preservation by the Association of Chemotherapy and Radiotherapy in Invasive Bladder Cancer
Current Drug Therapy Myeloid Derived Suppressor Cells and Their Role in Diseases
Current Medicinal Chemistry The Effects of Probiotics and Prebiotics on Gastrointestinal and Behavioural Symptoms in Autism Spectrum Disorder
Current Reviews in Clinical and Experimental Pharmacology Protease Inhibitors in the Clinic
Medicinal Chemistry Applications of Lipid based Formulation Technologies in the Delivery of Biotechnology-based Therapeutics
Current Pharmaceutical Biotechnology The Use of PET for Radiotherapy
Current Medical Imaging Novel Strategies and Model Studies for Colon Targeted Drug Delivery
Drug Delivery Letters Targeting Opioid and Neurokinin-1 Receptors to Treat Alcoholism
Current Medicinal Chemistry Pain Perception and Management: Where do We Stand?
Current Molecular Pharmacology The Roles of Mesenchymal Stem Cells in Tissue Repair and Disease Modification
Current Stem Cell Research & Therapy Angiogenic and Anti-Angiogenic Therapy for Gastrointestinal Ulcers: New Challenges for Rational Therapeutic Predictions and Drug Design
Current Pharmaceutical Design Overview of the Role of Annexin 1 in the Innate and Adaptive Immune Response
Immunology, Endocrine & Metabolic Agents in Medicinal Chemistry (Discontinued) Synthesis, Biological Evaluation and In Silico Study of β-Chloro Vinyl Chalcones as Inhibitors of the TNF-α, IL-6 With Anticancer and Antioxidant Activity
Letters in Drug Design & Discovery L-Arginine Modulates Glucose and Lipid Metabolism in Obesity and Diabetes
Current Protein & Peptide Science Role of Dietary Fiber and Short-Chain Fatty Acids in the Colon
Current Pharmaceutical Design Imaging Localised Hydrogen Peroxide Production in Living Systems
Current Chemical Biology Patent Selections
Recent Patents on Biomarkers Patent Selections
Recent Patents on DNA & Gene Sequences